Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients. Masset C, Kerleau C, Blancho G, Hourmant M, et al. Transpl Int 2023;36:10816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Masset C, Kerleau C, Blancho G, Hourmant M, et al. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients. Transpl Int 2023;36:10816.
PMID: 36819125